This statistic shows the number of deaths from cervical cancer in England from 2014 to 2021. In 2021, the number of deaths from cervical cancer reached 702, an increase from 681 deaths in 2020.

This publication reports on newly diagnosed cancers registered in England during 2022. It includes this summary report showing key findings, spreadsheet tables with more detailed estimates, and a methodology document. Cancer registration estimates are provided for: • Incidence of cancer using groupings that incorporate both the location and type of cancer by combinations of gender, age, deprivation, and stage at diagnosis (where appropriate) for England, former Government office regions, Cancer alliances and Integrated care boards • Incidence and mortality (using ICD-10 3-digit codes) by gender and age group for England, former Government office regions, Cancer alliances and Integrated care boards This publication will report on 2022 cancer registrations only, trends will not be reported as the required re-stated populations for 2012 to 2020 are not expected to be published by the Office of National Statistics (ONS) until Winter 2024.

This statistic shows the mortality rate per 100,000 population from cervical cancer in England from 2014 to 2021. The mortality rate has declined slightly since 2014 from 2.7 per 100,000 population to 2.5 per 100,000 population in 2021.

People between the ages of 25 and 64 are invited for regular cervical screening under the NHS Cervical Screening Programme. This is intended to detect abnormalities within the cervix that could, if undetected and untreated, develop into cervical cancer. This statistical report covers the NHS Cervical Screening Programme for England in 2023-2024. It includes data on the call and recall system, on screening samples examined by pathology laboratories and on subsequent referrals to colposcopy clinics.

This statistic shows the share of women screened for cervical cancer according to the cervical cancer screening program in England from 2011 to 2024. In 2024, 74.3 percent of women aged 50 to 64 received appropriate screening coverage.

This statistic shows the number of women registered with cervical cancer in England from 2011 to 2020. The number of women registered with cervical cancer in 2020 was approximately 2.3 thousand.

This statistic shows the share of women aged 25 to 64 who were screened under the cervical cancer screening program in England from 2011 to 2024. During this period, the share of women screened by the cervical cancer screening program fell from a high of 75.7 percent in 2011, to 68.8 percent in 2024.

Legacy unique identifier: P00188

This statistic shows the share of women who have been screened for cervical cancer in the past five years in England in 2023/24, by age. In this year, 77.1 percent of women between the ages 45 and 49 have been screened for cervical cancer in the past five years.

BackgroundCervical cancer is the fourth highest incidence of malignancy in the world and a common cause of cancer death in women. We assessed the trends of incidence and mortality and disability-adjusted life year (DALY) in China, England and India from 1990 to 2030.MethodData were obtained from the Global Burden of Disease (GBD) database. We collected the number and rate of incidence, death and DALY from 1990 to 2019 and calculated the estimated annual percentage change (EAPC). Further analysis was carried out by ages and years. We also collected attributable risk factors to cervical cancer. Finally, we utilized the Bayesian Age-Period-Cohort (BAPC) model to forecast trends in the rate of age-standardized incidence (ASIR) and age-standardized death (ASDR) the for the next decade.ResultGlobally, the incidence of cervical cancer cases increased from 335,641.56 in 1990 to 565,540.89 in 2019. In 2019, the ASIR and ASDR of cervical cancer were higher than those of India but lower than those of England. Furthermore, unsafe sex and smoking emerge as prominent risk factors for cervical cancer. Over the next decade, ASIR and ASDR are expected to decline in China and England, while India’s ASIR is still on an upward trend and ASDR is on a downward trend.ConclusionThe epidemiological data of cervical cancer in these three countries reflects the influence of different stages of development and healthcare systems. Trends over the next decade suggest that China and India still face a huge burden of cervical cancer. When England has made significant progress, China and India need to take more measures to improve the prevention and control of cervical cancer.

Deaths from cervical cancer - Directly age-Standardised Rates (DSR) per 100,000 population Source: Office for National Statistics (ONS) Publisher: Information Centre (IC) - Clinical and Health Outcomes Knowledge Base Geographies: Local Authority District (LAD), Government Office Region (GOR), National, Primary Care Trust (PCT), Strategic Health Authority (SHA) Geographic coverage: England Time coverage: 2005-07, 2007 Type of data: Administrative data

The proportion of women in the resident population eligible for cervical screening aged 25 to 49 years at end of period reported who were screened adequately within the previous 3.5 years.RationaleCervical screening supports detection of cell abnormalities that may become cancer and is estimated to save 4,500 lives in England each year. Inclusion of this indicator provides an opportunity to incentivise screening promotion and other local initiatives to increase coverage of cervical cancer screening.Improvements in coverage would mean more cervical cancer is prevented or detected at earlier, more treatable stages.Definition of numeratorTested women (numerator) is the number of eligible women with a technically adequate screen within the previous 3.5 years.Definition of denominatorEligible women (denominator) is the number of women aged 25 to 49 years resident in the area (determined by postcode of residence) who are eligible for cervical screening at a given point in time, excluding those without a cervix.CaveatsData for ICBs are estimated from local authority data. In most cases ICBs are coterminous with local authorities, so the ICB figures are precise. In cases where local authorities cross ICB boundaries, the local authority data are proportionally split between ICBs, based on population located in each ICB.The affected ICBs are:Bath and North East Somerset, Swindon and Wiltshire;Bedfordshire, Luton and Milton Keynes;Buckinghamshire, Oxfordshire and Berkshire West;Cambridgeshire and Peterborough;Frimley;Hampshire and Isle of Wight;Hertfordshire and West Essex;Humber and North Yorkshire;Lancashire and South Cumbria;Norfolk and Waveney;North East and North Cumbria;Suffolk and North East Essex;Surrey Heartlands;Sussex;West Yorkshire.Please be aware that the April 2019 to March 2020, April 2020 to March 2021 and April 2021 to March 2022 data covers the time period affected by the COVID19 pandemic and therefore data for this period should be interpreted with caution.This indicator gives screening coverage by local authority of residence. This is not the same as the indicator based on population registered with primary care organisations which include patients wherever they live. This is likely to result in different England totals depending on selected (registered or resident) population footprint.The indicator excludes women outside the target age range for the screening programme who may self refer for screening.

Cervical cancer is a type of cancer that occurs in the cells of the cervix, which connects the vagina (birth canal) to the upper part of the uterus (Mayo Clinic, 2021). All women are at risk for cervical cancer. It occurs most often in women ages 30 years and older (Centers for Disease Control and Prevention, 2021). Long-lasting infection with certain types of human papillomavirus (HPV) is the main cause of cervical cancer. Almost all cervical cancer cases (99%) are linked to infection with HPV, an extremely common virus transmitted through sexual contact (World Health Organization, 2021). In 2018, an estimated 570,000 women were diagnosed with cervical cancer worldwide, and about 311,000 women died from the disease (World Health Organization, 2021).
In the 8MM, diagnosed incident cases of cervical cancer are expected to increase from 109,891cases in 2020 to 123,846 cases in 2030, at an Annual Growth Rate (AGR) of 1.27%. In 2030, urban China will have the highest number of diagnosed incident cases of cervical cancer in the 8MM, with 83,479 cases, whereas Spain will have the fewest diagnosed incident cases of cervical cancer with 2,147 cases. In the 8MM, the five-year diagnosed prevalent cases of cervical cancer are expected to increase from 394,378 cases in 2020 to 453,614 cases in 2030, at an AGR of 1.50%. GlobalData epidemiologists attribute the increase in the five-year diagnosed prevalent cases and diagnosed incident cases of cervical cancer to changes in the diagnosed incidence and survival rates, and population dynamics in each market. Read More

This statistic shows the number of women between the age of 20 and 64 invited for cervical cancer screening in England from 2011 to 2024. In 2024, the number of women invited for cervical cancer screening reached 5.32 million, an increase with respect to the preceding year (4.82 million).

This statistic shows the number of women tested for cervical cancer with results showing borderline changes or low-grade abnormalities in England from 2011 to 2024. The number of women tested with results of low-grade abnormalities amounted to approximately 140 thousand in 2024.

Years of Life Lost (YLL) as a result of death from cervical cancer - Directly age-Standardised Rates (DSR) per 100,000 population Source: Office for National Statistics (ONS) Publisher: Information Centre (IC) - Clinical and Health Outcomes Knowledge Base Geographies: Local Authority District (LAD), Government Office Region (GOR), National, Primary Care Trust (PCT), Strategic Health Authority (SHA) Geographic coverage: England Time coverage: 2005-07, 2007 Type of data: Administrative data

The cancer services profiles have been updated to split the existing indicator ‘Females, 25 to 64, attending cervical screening within target period (3.5 or 5.5 year coverage, %)’ by age group (25 to 49 and 50 to 64), creating 2 new and distinct indicators. All other indicators for the cancer services profile were released on 1 December 2020.

These profiles present data at GP, Clinical Commissioning Group (CCG) and national level on:

• cancer incidence and screening
• Two Week Wait (TWW) referrals
• diagnostic services
• emergency presentations and admissions

The https://fingertips.phe.org.uk/profile/cancerservices" class="govuk-link">cancer services profiles have been designed to support commissioners and health professionals to assess the impact of cancer on their local population and make decisions about services.

These profiles replace the GP cancer profiles that were previously presented in the Cancer Commissioning Toolkit.

Mortality from cervical cancer (ICD-10 C53 equivalent to ICD-9 180). To reduce deaths from cervical cancer. Legacy unique identifier: P00189

This statistic shows the number of cervical test samples examined in England from 2011 to 2024. There were 3.19 million test samples examined in 2023/24. Cervical cancer is the growth of abnormal cells in the lining of the cervix.